Clinical trial
A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors
NCT05784597
Study timeline
Study start (actual)2023-04-27Date precision: day
Registry last updated2024-11-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Colorectal Cancerunresolved
Oesophageal Cancerunresolved
Pancreas Adenocarcinomaunresolved
Interventions
Sponsors & collaborators
Philogen S.p.A.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05784597 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.